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Abstract 
 
Hypertension is a chronic disease that requires an intensive monitoring from time to time to prevent 
complications leading to cardiovascular disease. In addition, its complex health needs have an effect on 
the treatment process and the motivation of the patient for treatment. Therefore, pharmacist counseling 
is expected to provide information to patients in handling health problems, especially related to the 
treatment of hypertension. Counseling is expected to provide behavioral changes to optimize therapeutic 
effects and improve the quality of life of patients. The purpose of this study is to analyze the influence of 
pharmacist counseling on the success of therapy and quality of life of hypertensive patients. The study 
was conducted at a hospital in Kupang, East Nusa Tenggara to outpatients in Depo Induk implementing 
true experimental design and pretest posttest with control group with simple random sampling method 
during April - June 2017. The data collection included blood pressure, age, gender, education level, 
treatment success seen from decreased or controlled blood pressure, and quality of life with Short Form-
36 (SF-36). The subjects of the study were 100 people divided into 50 people in the non-counseling 
group (who merely received information on medication as usual by pharmacist in Depo Induk) and 50 
people in the counseling group (who received drug information service as usual by pharmacist in Depo 
Induk and individual counseling by pharmacist/researcher). Counseling was given in the form of giving 
insight about drugs, hypertension, and non-pharmacological approach (lifestyle modification) in 
managing hypertension. The results showed that with counseling, pharmacists can improve treatment 
success proven by the decrease of systolic blood pressure (-9 mmHg, p=0,000) and diastolic blood 
pressure (-7 mmHg, p=0,000); improve the quality of life of hypertensive patients with p<0.000 value of 
both pre and posttest and treatment (counseling) and also validated by final data test results between 
non-counseling group and counseling group. 
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 Introduction 1.
 
Hypertension is a common cause of cardiovascular disease, widely recognized as the most 
common cardiovascular disorder and the number one risk factor for mortality. Hypertension causes 
at least 45% of deaths due to heart disease and 51% of deaths due to stroke. Almost 50% of 17.5 
million deaths in the world are caused by cardiovascular disease associated with systemic arterial 
hypertension disease. The prevalence of hypertension in Indonesia in 2013 is 9.5%, 7.4% in Nusa 
Tenggara Timur, and 6.3% in Kupang. 
Management of pharmacological aspects in controlling blood pressure has been implemented, 
but there is still an increase in complications related to hypertension. Some complications occurred 
due to poor treatment in controlling blood pressure such as coronary heart disease, peripheral 
vascular disease, and kidney disorders. Achievement of blood pressure control in addition to 
pharmacological approaches is also influenced by nonpharmacological aspects such as diet and 
physical activity so that the role of pharmacist in determining the success of hypertension therapy is 
highly needed. 
The therapeutic problems of patients with chronic diseases are related to adherence to 
therapy so that pharmacists as pharmaceutical professionals are responsible for providing 
education through counseling to patients to make them understand the goals of therapy change 
and adhere to healthy lifestyles, and improve medication adherence. 
The quality of life (QoL) of hypertensive patients is influenced by several socio-demographic 
factors such as age, gender, education, and family history of hypertension. Quality of life is also 
directly affected by the lack of education, lifestyle modification, and low levels of patient 
understanding on the management of the disease. Quality of life (QoL) is a complex concept. 
Therefore, to assess the outcomes of interventions related to quality of life, it uses the SF-36 
questionnaire which is one of the generic instruments used to measure overall quality of life in 
general in patients with chronic diseases such as hypertension.20 SF-36 assess 8 (eight) domains 
that include, physical function (10 questions), physical limitations (4 questions), body pain (2 
questions), general health (6 questions), vitality (4 questions), social function (2 questions), 
emotional limitation (3 questions), and mental health (5 questions). 
In East Nusa Tenggara, especially Kupang, pharmaceutical services in the field of clinical 
pharmacy, especially counseling, is still minimal. This is related to the lack of pharmacists. 
Pharmaceutical services in hospitals for outpatients, especially in Depo Induk, exceed the ratio of 
1:50 with the number of pharmacist’s as much as two people and the average visit of 175 patients. 
Pharmaceutical services provided when delivering drugs to patients are merely limited to drug 
name information, indications, and rules of use. This condition ultimately affects the lack of 
information about drugs, hypertension, and lifestyle modifications for patients when getting drugs. 
Based on the above information, the research was conducted to analyze the influence of 
counseling pharmacist to the success of therapy and the quality of life of hypertensive patients in a 
hospital in East Nusa Tenggara. 
 
 Method 2.
 
2.1 Research Subject 
 
The research was designed in a pretest posttest study with control group. The subjects were 
hypertensive outpatients who become the participant of National Health Insurance (Jaminan 
Kesehatan Nasional/JKN) and perform and take medication at Depo Induk at East Nusa Tenggara 
Hospital from April to June 2017. The subjects were selected through a simple randomized study in 
patients diagnosed as suffering hypertension with or without complications, ≥18 years old and ≤65 
year’s old, receiving two kinds of drugs, known for their blood pressure values, and willing to 
participate in the study by signing informed consent. 
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2.2 Number of Research Subjects 
 
The number of research subjects was obtained using the formula of proportion based on the 
prevalence of hypertension occurrence in Kupang (6.3%) and 10% to fill the possibility of drop out 
so that the total subjects were 100 people. The subjects were divided into two groups, i.e. 50 
people in the non-counseling group (only receiving drug information services as usual by 
pharmacists in Depo Indah) and 50 people in the counseling group (receiving drug information 
service as usual by pharmacist in Depo Indah and counseling by researchers). In Depo Induk, the 
drug information is usually given in the form of drug name, indication, and rule of use. 
 
2.3 Research Instrument 
 
The instrument used is questionnaire. To measure the quality of life, Indonesia version of SF-36 
questionnaire was used consisting of 36 questions divided into 8 domains. They are physical 
function (10 questions), physical limitations (4 questions), body pain (2 questions), general health (6 
questions), vitality (4 questions), social function (2 questions), emotional limitation (3 questions), 
and mental health (5 questions). The questionnaires have been tested valid and reliable to measure 
the quality of life of hypertensive patients. 
 
2.4 Data Collection 
 
The data were prospectively collected from hypertensive patients who meet the criteria in 30 days. 
The data collection included age, sex, education level, occupation, blood pressure, and filling out 
the Indonesian version of SF-36 questionnaire. After one month when the subjects returned to do 
medical checkup, the final data were taken in the form of blood pressure and filling out the 
Indonesian version of the SF-36 questionnaire. Filling out questionnaires was done by research 
subjects while waiting for drug preparation. 
 
2.5 Procedures and Treatment 
 
Research subjects who met the criteria of inclusion and exclusion were randomly selected. 
Research subjects were informed of their voluntary participation and guaranteed that all their 
personal data will be kept confidential, and they are entitled to withdraw at any time during the 
study without having to give a reason. Proof of voluntary participation is by signing the informed 
consent. This research does not interfere with service process where the research subjects still get 
drug information service as usual by pharmacist at Depo Induk Hospital. The difference is there is 
additional service in the form of counseling to the counseling group. Treatment in the form of 
counseling was given by the pharmacist as a researcher. Counseling is an individualized 
educational intervention provided in a special counseling room with duration of 15-30 minutes 
(according to time agreement with the subject). Educational interventions were provided after 
ensuring the understanding of research subjects on the drug, hypertension diseases, and lifestyle 
modifications. Educational intervention in the form of counseling to the subject of research is 
provided without cost. 
 
2.6 Analysis 
 
The demographic data of research subjects were analyzed by descriptive statistics. Score/value of 
blood pressure and quality of life tested in distribution normality using Kolmogorov-Smirnov test. 
Normally distributed data were tested using parametric statistics, t test (for paired and free 
samples) and non-distributed data were resumed by different test with non-parametric statistic 
method, Wilcoxon test (for pre-post sample), and Mann Whitney test (For free samples in this case 
non-counseling and counseling groups). 
Effect of treatment in the form of pharmacist counseling was determined by comparing blood 
pressure and quality of life before and after treatment. 
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 Results 3.
 
The characteristics of the demographic of subjects who met the inclusion and exclusion criteria 
were 100 people divided randomly in two groups: 50 people in non-counseling group and 50 people 
in counseling group. The results of demographic parameters of female hypertensive patients 
(57/100) were more numerous than male (43/100). Mostly the age of the patients are 54-65 years 
old (60/100) followed by the age of 42- 53 years (32/100) as much as 60 people. The educational 
background of the patients varies, in which 47 people (47/100) graduated from high school followed 
by university level (28/100), elementary school (13/100) and junior high school (12/100). (Table 1.) 
  
Table 1. Distribution of Research Subject Demographics 
 
Demographics Non-counseling (n=50) Counseling (n=50) Total (n=100) N % N % n % 
Sex 
Male 20 40 23 46 43 43 
Female 30 60 27 54 57 57 
Age (years) 
18-29 1 2 1 2 2 2 
30-41 3 6 3 6 6 6 
42-53 13 26 19 38 32 32 
54-65 33 66 27 54 60 60 
Level of Education 
Elementary School 7 14 6 12 13 13 
Junior High School 7 14 5 10 12 12 
High School 24 48 23 46 47 47 
University Level 12 24 16 32 28 28 
 
Differences in mean values of baseline blood pressure and end of observation in the subjects of non-
counseling group are not significant (p> 0,05) both systolic blood pressure (p = 0,352) and diastolic 
blood pressure (p = 0,559). On the other hand, in counseling group, there was a significant difference 
(p <0.05) in both systolic blood pressure (p = 0,000) and diastolic blood pressure (p = 0.000). This 
data indicates a change in blood pressure in the group who received treatment in the form of 
pharmacist counseling. These results indicate that pharmacist counseling has a positive effect on 
decreasing systolic blood pressure (-9mmHg, p=0,000) and diastolic blood pressure (-7mmHg, 
p=0,000). Differences in mean values of blood pressure variables between pre-post non-counseling 
groups and pre-post counseling groups are presented in Table 2. 
 
Table 2. Differences in Mean Value of Blood Pressure Variable (pre-post)  
 
Criteria 
Non-counseling Counseling 
Mean ∆ 
(Post – Pre) p 
Mean ∆ 
(Post – Pre) p Pre Post Pre Post 
Systolic Blood Pressure 133,8 135,6 1,8 0,352 135,6 126,6 -9 0,000 
Diastolic Blood Pressure 84,4 85,2 0,8 0,559 85,6 78,6 -7 0,000 
 
In Table 3, the results of Mann Whitney test to the initial data (pre) of non-counseling group and 
counseling group for the indicator value of systolic blood pressure (p = 0.501) and diastolic blood 
pressure (p = 0.653) is not different (p> 0.05). In other word, (pre) systolic or diastolic blood 
pressure of the whole research subjects is the same or no significant difference. Different test of 
non-counseling group and counseling group for indicator value of systolic blood pressure (p = 
0,000) and diastolic blood pressure (p = 0,000) showed p value <0,05 meaning that there was a 
difference of blood pressure indicator value between non-counseling group and counseling group at 
the end of the observation. These results indicate the success of therapy in the form of decreasing 
both systolic and diastolic blood pressure influenced by the pharmacist counseling. Based on the 
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results of the interview, the patients revealed that the received pharmacist counseling made them 
become more understand the drugs, hypertension disease, and lifestyle modification and influence 
on the motivation of patients in the use of accepted drugs. 
 
Table. 3 Mean of Blood Pressure and Compliance Variables (pre-pre and post-post) 
 
Variable Pre non- counseling 
Pre 
counseling P 
Post non- 
counseling 
Post 
counseling P 
Systolic Blood Pressure 133,8 135,6 0,501 135,6 126,6 0,000 
Diastolic Blood Pressure 84,4 85,2 0,653 85,2 78,6 0,000 
 
The mean difference in scores of quality of life variables is based on the filling of the SF-36 
questionnaire done by pre-post research subjects. In the non-counseling group for the domain of 
physical function (p=0.771), general health (p=0.563), social function (p=0.099), and emotional 
limitation (p=0.191), there is no difference in the average number of scoring the initial data and the 
final data (one month after initial data retrieval without treatment) with p> 0,05. However, in physical 
function domain (0,021), body pain (p = 0,006), vitality (p = 0,000), and mental health (p = 0,020), 
there is an average difference in scores. The increase in the average number of scoring on non-
counseling group before and after one month of observation for the domain of physical function, 
body pain, and general health is influenced by the drugs given to deal with complaints/clinical 
symptoms felt by the subject of current research health control to hospital (initial observation). 
Drugs given to deal with complaints/clinical symptoms in question are such as headache, low back 
pain (LBP) (paracetamol, diclofenac, meloxicam), abdominal pain (lansoprazole, Ranitidine, 
Ulsidex, Omeprazole), tingling, muscle cramps (Gabapentin, vitamin Neurotrophic), and depression 
(Amitriptyline). 
The increase in the mean scoring value of the domain of emotional limitation might be related 
to the age of the subjects in non-counseling group included in the criteria for adults (approximately 
55.74 ± 8.79 years), so that the subjects emotionally/psychologically have been able to accept the 
conditions/circumstances experienced. The mean of quality of life score of hypertensive patients 
(pre-post) is presented in Table 4. 
Generally, in the counseling group, there is a significant difference in the value of quality of life 
indicators before and after counseling on eight domains. The increase in the mean score before 
and after counseling on eight domains showed besides the drugs given during health controls to the 
hospital, there is intervention in the form of pharmacist counseling on the additional information 
regarding side effects of medication, hypertension, possible complications, the need for regular 
treatment and drug use as recommended, and lifestyle modification. In addition, based on 
interviews with research subjects, they feel the attention and motivation of the pharmacist as a 
provider of health services when getting counseling. 
 
Table 4. Mean Score of Variable Quality of Life of Hypertensive Patients (pre-post) 
 
Domain 
Non-counseling  Counseling 
Mean ∆ P Mean ∆ P Pre Post (Post - Pre) Pre Post (Post - Pre) 
physical function 65,00 62,60 -2,40 0,021 59,70 76,20 16,50 0,000 
physical limitations 16,53 18,00 1,47 0,771 10,50 65,50 55,00 0,000 
body pain 49,00 61,75 12,75 0,006 57,50 86,00 28,50 0,000 
general health 366,83 50,42 13,59 0,563 49,75 81,08 31,33 0,000 
Vitality 62,20 59,00 -3,20 0,000 57,10 77,40 20.30 0,000 
social function 48,00 57,75 9,75 0,099 57,75 77,50 19,75 0,000 
emotional limitation 20,00 28,67 8,67 0,191 15,33 59,36 44,03 0,000 
mental health 70,56 69,36 -1,20 0,020 62,48 87,60 25,12 0,000 
 
The result of test of difference of indicator of quality of life which consist of eight domains between 
preliminary data in non-counseling and counseling group shows no significant difference (p> 0,05). 
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On the contrary, in post data between non-counseling and counseling group, there is no significant 
different in indicator value (p <0,05). This shows that the difference in the value of this indicator is 
due to the effect of the intervention in the form of pharmacist counseling. Test results are presented 
in Table 5. 
 
Table 5. Mean Score of Quality of Life Variable of Hypertensive Patients (pre-pre and post-post) 
 
Domain Pre non-counseling 
Pre 
counseling P 
Post non-
counseling 
Post 
counseling p 
physical function 65,00 59,70 0,259 62,60 76,20 0,000 
physical limitations 16,53 0,50 0,215 18,00 65,50 0,000 
body pain 49,00 57,50 0,966 61,75 86,00 0,000 
general health 36,83 49,75 0,643 50,42 81,08 0,000 
Vitality 62,20 57,10 0,153 59,00 77,40 0,000 
social function 48,00 57,75 0,587 57,75 77,50 0,000 
emotional limitation 20,00 15,33 0,256 28,67 59,36 0,000 
mental health 70,56 62,48 0,052 69,36 87,60 0,000 
 
 Research Ethics 4.
 
The research was conducted after obtaining ethical permit from Health Research Ethics Committee 
of Faculty of Medicine, University of Nusa Cendana Kupang with the number of Letter of 
Recommendation of Ethical Approval: 02a/UN15.16/KEPK/2017, dated March 15, 2017. In this 
research, there are two groups which are non-counseling group and counseling group. Therefore, 
by considering ethical aspect, at the end of research, the subjects in non-counseling group are 
given treatment in the form of pharmacist counseling so there is no difference of treatment between 
both research groups. 
 
 Discussion 5.
 
The results of this study indicated hypertensive patients are more dominated with female patients 
than male and the prevalence of hypertension mostly occurred at the age of 42-65 years. These 
results suggested that the diagnosis of hypertension begins at age ≥18 years and increases with 
age. In most cases, the increase in blood pressure correlates with increasing age and tends to be 
higher in women than in men. In addition, the majority of patients have a good level of education. 
Most of the patient’s mistakes are caused by the lack of understanding on treatment regimens such 
as dosage or self-regulation of the treatment regimen. The key role of the pharmacist in helping 
patients get the best therapeutic results is by providing pharmaceutical counseling services. 
Pharmacist counseling is one of pharmaceutical service responsibilities to improve patient 
understanding of treatment with the ultimate goal of achieving definite results of improving and/or 
maintaining patient quality of life. 
Pharmacist counseling can help to manage chronic diseases such as hypertension. What is 
given during counseling are in the form of attention, motivation, knowledge of medicines, 
hypertension, and lifestyle modification. This study showed an improvement in blood pressure, 
which in turn has an impact on the improvement of quality of life of hypertensive patients. These 
results were shown by differences in pre-post treatment outcomes and also validated as a result of 
treatment in the form of pharmacist counseling with different post test results in both groups. The 
role of pharmacists in the management of chronic diseases through counseling has reduced the 
information gaps related to complications. Based on the results of interviews, patients have the 
understanding that complications of kidney disorders is caused by long-term use of drugs so that 
hypertension medication is mostly done when the complaints/clinical symptoms in the form of 
headache and shoulder pain occur. Similar results by Mollaoğlu, et al (2015) also showed that drug 
is consumed only if there are clinical symptoms. 
Uncontrolled blood pressure mostly can lead to the decrease of quality of life of patients. This 
is due to poor medical compliance and lack of knowledge and awareness of hypertension. 
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In this study, pharmacist counseling provided the motivation for the patient not to be afraid of 
the side effects of the drug. In addition, it gave information related to the side effects of the drug 
and its treatment so that the patient consumed the drugs based on the rules without feeling fear of 
the side effects of the drug. The result of interviews with patients showed that they are afraid of 
taking drugs in the long term continuously with the consideration that the drugs received are 
chemicals and can cause interference effects on organs such as the kidney. Besides, drug use also 
becomes irregular due to perceived side effects such as cough and frequent urination during the 
night day. 
 
 Conclusion 6.
 
This study showed that the role of the pharmacist in providing counseling to hypertensive patients 
has a positive impact in improving the patient’s understanding of medication, hypertension, and 
lifestyle modification to achieve maximum therapeutic effect and ultimately improve patient’s quality 
of life. In addition, the involvement of pharmacists in the therapeutic and management process of 
hypertensive diseases is highly significant because there is information gap related to the use of 
drugs obtained during health control. 
The results of this study indicated that pharmacist counseling could improve the therapeutic 
efficacy and quality of life of hypertensive patients. Therefore, it is expected to increase the role of 
pharmacists in the process of management of chronic diseases such as hypertension. Increasing 
the role of pharmacists through pharmaceutical services in the field of clinical pharmacy in the form 
of counseling can ultimately help to reduce the burden of the health system and can reduce drug-
related problems, management of chronic diseases, and lifestyle modification of hypertensive 
patients in Kupang, East Nusa Tenggara. 
 
 Strengths and Limitations 7.
 
What becomes the strength of this study is the success of therapy and quality of life influenced by 
the intervention in the form of pharmacist counseling. This is evidenced by the result of research 
using pretest-posttest design with a control group whose members were chosen randomly so that 
the states of both groups were equal before treatment. 
The limitation of this study is that the observation time is relatively short so it cannot guarantee 
the continuity of patient compliance in carrying out the therapy and lifestyle modification. However, 
the results of this study provide data that the intervention in the form of pharmacist counseling 
contributes to behavior change, the achievement of therapeutic effect, and quality of life of the 
patient. 
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